EvolveImmune Therapeutics is dedicated to transforming patient outcomes in oncology through its “Immunology First” approach, creating first-in-category cancer medicines that aim to deliver superior, lasting results over current therapies. As pioneers in cancer treatment, EvolveImmune quickly translates scientific discoveries into breakthrough innovations, addressing critical unmet medical needs in cancer with differentiated therapeutic solutions.